Skip to main content
Clinical Trials/NCT06274112
NCT06274112
Recruiting
Not Applicable

Personalized Neuromodulation Targeting Dysregulated Motivational Responses Underlying Social Avoidance Behavior

Auburn University1 site in 1 country40 target enrollmentSeptember 30, 2025

Overview

Phase
Not Applicable
Intervention
TMS
Conditions
Social Avoidant Behavior
Sponsor
Auburn University
Enrollment
40
Locations
1
Primary Endpoint
Neural circuit function
Status
Recruiting
Last Updated
2 months ago

Overview

Brief Summary

The purpose of this study is to use transcranial magnetic stimulation (TMS) to better understand the neural circuits associated with social motivation.

Participant includes four study visits each that range from 1.5 - 3.0 hours in duration over approximately a one month period. The first study visit involves answering survey questions, a clinical interview, and computer tasks. The second study visit involves a magnetic resonance imaging (MRI) scan, computer tasks, and a brief TMS protocol. The second and third study visits involve a full session of TMS followed by an MRI scan and computer tasks.

Adults in the Auburn/Opelika area and surrounding areas who avoid social situations, experience symptoms of depression or social anxiety, and are between 25 years old and 50 years old are eligible to participate.

Registry
clinicaltrials.gov
Start Date
September 30, 2025
End Date
July 31, 2029
Last Updated
2 months ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Travis Evans

Assistant Professor

Auburn University

Eligibility Criteria

Inclusion Criteria

  • A diagnosis of Major Depressive Disorder OR a diagnosis of Social Anxiety Disorder (assessed/confirmed at screening visit).
  • Scoring above clinical threshold on a measure of social avoidant behavior (assessed/confirmed at phone screen).

Exclusion Criteria

  • Unstable psychotropic medication regimen (i.e., changes in psychotropic medication or dosage in past 3 months).
  • Current or lifetime diagnosis of Bipolar Disorder.
  • A diagnosis of substance use disorder within past 12 months.
  • A diagnosis of psychotic-spectrum disorder such as Schizophrenia.
  • Pregnancy or probable pregnancy.
  • Medical illness or medical treatment that would preclude or inhibit study participation.
  • Neurological disorder associated with brain damage.
  • History of seizures or head trauma with loss of consciousness \> 5 minutes.
  • Family history of epilepsy or personal epilepsy/seizures
  • Ferromagnetic implants or ferrmagnetic objects within body (e.g., pacemaker).

Arms & Interventions

TMS A

Active continuous thetaburst stimulation administered over right dorsolateral prefrontal cortex for 40 seconds (600 pulses total)

Intervention: TMS

TMS B

Sham continuous thetaburst stimulation administered over right dorsolateral prefrontal cortex for 40 seconds (600 pulses total)

Intervention: TMS

Outcomes

Primary Outcomes

Neural circuit function

Time Frame: Immediately post-intervention

Brain connectivity during motivational responses to facial expression during the Social Approach-Avoidance Paradigm (SAAP; Evans, Esterman, \& Britton, 2022) and during resting state conditions. In the SAAP, participants self-report how much they would like to approach or avoid emotional facial expressions. During resting state conditions, participants simply lie still with their eyes open without completing any type of task.

Social motivation

Time Frame: Immediately post-intervention

Motivational responses to facial expressions as measured by the Social Approach Avoidance Paradigm (SAAP; Evans, Esterman, \& Britton, 2022). In the SAAP, participants self-report how much they would like to approach or avoid emotional facial expressions.

Study Sites (1)

Loading locations...

Similar Trials